Jefferies: MannKind's Consumer Ads For Afrezza May Increase Awareness

By: via Benzinga
MannKind Corporation (NASDAQ: MNKD)'s plans for direct-to-consumer advertising for its Afrezza inhaled insulin product may ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.